Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Alessandra Nerviani et al.|The Lancet|2021Cited by 315
Society of Academic and Research SurgeryPreetesh Jain, Patricia Shaw, A. R. Anderson et al.|British journal of surgery|2004Cited by 0
Society of Academic and Research SurgeryGuy C. Warner, H. P. Redmond, Patrícia P. Reis et al.|British journal of surgery|2004Cited by 0